Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-705-0 | CAS number: 98-83-9
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
In vitro studies (bold = Key Study)
Huels AG (1989), Amoco Co. (1991), Zeiger et al. (1992),MHW Japan (1997), NTP (2007):
negative in Salmonella typhimurium TA 100, TA 1535, TA 1538, TA 98, TA 97, TA 1537 and Escherichia coli WP2 uvrA (with or without metabolic activation; study design comparable to OECD Guidelines No. 471 and 472)
MHW Japan (1997): no chromosomal aberrations or polyploidy in Chinese hamster lung cells (CHL/IU; with or without metabolic activation; study design comparable to OECD Guideline No. 473)
Amoco Co. (1991) / NTP (2007): no chromosomal aberrations in CHO cells (with or without metabolic activation; study design comparable to OECD Guideline No. 473)
Amoco Co. (1991): negative in the CHO/HGPT mutation assay (with or without metabolic activation; study design comparable to OECD Guideline No. 476)
NTP (2007): sister chromatid exchanges in CHO cells: positive with metabolic activation and negative without metabolic activation (study design comparable to OECD Guideline No. 479)
Norppa & Vainio (1983): sister chromatid exchange assay in lymphocyte cultures of a healthy male donor: ambiguous without metabolic activation
In vivo studies:
NTP (2007): micronucleus assay with a study comparable to OECD Guideline No. 474: no significant increases in the frequencies of micronucleated erythrocytes in blood samples of male mice obtained at the conclusion of the 3-month study, but significant increase in micronucleated erythrocytes in high-dosed (1000 ppm) females. Reticulocytes (polychromatic immature erythrocytes; PCEs) were also scored for frequency of micronucleated cells in male and female mice. No increase in micronucleated PCEs was observed in either sex at the highest exposure concentration of 1000 ppm, indicating that the damage observed in the mature erythrocyte population in 1000 ppm females was reflective of long-term accumulation of damage and was not detectable immediately after exposure by analyzing recently-formed (within 48 hours) reticulocytes. In view of the nature of the observed increases in micronucleated cells in these female mice and the clear absence of clastogenic effect observed in mammalian cells in vitro, the significance of this weak positive result is uncertain (high dose only, without trend).
Short description of key information:
With alpha-methylstyrene a variety of different in vitro and in vivo studies have been performed, which in total gave no indication for a mutagenic/genotoxic potential of the substance.
Endpoint Conclusion: No adverse effect observed (negative)
Justification for classification or non-classification
Based on the available and valid in vitro and in vivo data a classification is not needed.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
